IL139961A0 - Composition based on pentoxifylline and anticytokin - Google Patents

Composition based on pentoxifylline and anticytokin

Info

Publication number
IL139961A0
IL139961A0 IL13996199A IL13996199A IL139961A0 IL 139961 A0 IL139961 A0 IL 139961A0 IL 13996199 A IL13996199 A IL 13996199A IL 13996199 A IL13996199 A IL 13996199A IL 139961 A0 IL139961 A0 IL 139961A0
Authority
IL
Israel
Prior art keywords
anticytokin
pentoxifylline
composition based
composition
Prior art date
Application number
IL13996199A
Original Assignee
Commissariat Energie Atomique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique filed Critical Commissariat Energie Atomique
Publication of IL139961A0 publication Critical patent/IL139961A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13996199A 1998-05-29 1999-05-21 Composition based on pentoxifylline and anticytokin IL139961A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9806807A FR2779063A1 (en) 1998-05-29 1998-05-29 PENTOXIFYLLIN COMPOSITIONS AND THEIR THERAPEUTIC USE
PCT/FR1999/001208 WO1999062543A1 (en) 1998-05-29 1999-05-21 Composition based on pentoxifylline and anticytokin

Publications (1)

Publication Number Publication Date
IL139961A0 true IL139961A0 (en) 2002-02-10

Family

ID=9526861

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13996199A IL139961A0 (en) 1998-05-29 1999-05-21 Composition based on pentoxifylline and anticytokin

Country Status (9)

Country Link
EP (1) EP1079852B1 (en)
JP (1) JP2002528384A (en)
AU (1) AU3830899A (en)
CA (1) CA2333776A1 (en)
DE (1) DE69900336T2 (en)
ES (1) ES2165734T3 (en)
FR (1) FR2779063A1 (en)
IL (1) IL139961A0 (en)
WO (1) WO1999062543A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294350B1 (en) * 1997-06-05 2001-09-25 Dalhousie University Methods for treating fibroproliferative diseases
FR2862879B1 (en) * 2003-11-27 2006-04-28 Alchimer S A ORGANIC BIOACTIVE COATINGS APPLICABLE TO VASCULAR STENTS
EP2219650B1 (en) 2007-10-26 2014-05-07 Pacific Therapeutics Ltd. Compositions and methods for treating fibroproliferative disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332041C2 (en) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Use of pentoxifylline in certain lung diseases

Also Published As

Publication number Publication date
CA2333776A1 (en) 1999-12-09
DE69900336D1 (en) 2001-11-08
WO1999062543A1 (en) 1999-12-09
DE69900336T2 (en) 2002-06-27
EP1079852B1 (en) 2001-10-04
FR2779063A1 (en) 1999-12-03
ES2165734T3 (en) 2002-03-16
AU3830899A (en) 1999-12-20
EP1079852A1 (en) 2001-03-07
JP2002528384A (en) 2002-09-03

Similar Documents

Publication Publication Date Title
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
EP1021185A4 (en) Didhydropyrimidines and uses thereof
DE69927412D1 (en) Phosphitadditive in polyolefinen
EP1102535A4 (en) Compounds and methods
GB9813271D0 (en) Composition and use
ZA200101933B (en) Novel composition and use
BG105437A (en) Rheoogy modified compositions and processes thereof
EP1056456A4 (en) R-lansoprazole compositions and methods
GB9717598D0 (en) Novel composition and use
EP1056457A4 (en) S-lansoprazole compositions and methods
GB9811168D0 (en) Direct hair-colouring compositions and the use thereof
EP1073333A4 (en) S-rabeprazole compositions and methods
HUP0102109A3 (en) Sweetener composition and uses thereof
SG71754A1 (en) Copolymer and copolymer composition
PL331523A1 (en) Azolotrizines and azolopyrimidines
GB9608505D0 (en) Compositions processes and uses
IL139961A0 (en) Composition based on pentoxifylline and anticytokin
EP0998578A4 (en) Sel-10 AND USES THEREOF
GB9718636D0 (en) Novel composition and use
EP1073332A4 (en) R-rabeprazole compositions and methods
HUP9900068A3 (en) Fuse-switch and/or fuse-disconnector
EP1139972A4 (en) Dihydropyrimidines and uses thereof
EP1066051A4 (en) Sciellin and uses thereof
EP1071434A4 (en) Cnre binding factors and uses thereof